Literature DB >> 28480752

The Evaluation of D-Dimer Levels for the Comparison of Fibrinogen and Fibrin Units Using Different D-Dimer Kits to Diagnose VTE.

Masahiro Hasegawa1, Hideo Wada2, Toshio Yamaguchi1, Hiroki Wakabayashi1, Naoki Fujimoto2, Takeshi Matsumoto3, Kei Hasegawa4, Norikazu Yamada5, Masaaki Ito5, Yoshiki Yamashita6, Naoyuki Katayama6, Kaname Nakatani4, Akihiro Sudo1.   

Abstract

The cutoff values of D-dimer levels for diagnosing or predicting the occurrence of deep vein thrombosis (DVT) were evaluated in preoperative patients and compared to those in non-DVT patients. The levels of 8 different D-dimers were measured using the latex agglutination method or enzyme immunoassay before surgery in 262 orthopedic surgery patients to diagnose subclinical DVT or predict postoperative DVT. There were 15 patients with subclinical DVT and 47 with postoperative DVT, but 200 patients had no DVT at all. All 8 plasma D-dimer values were significantly higher in the patients with subclinical or postoperative DVT than in those without DVT or in healthy volunteers. There were differences in the cutoff values between the assays highly sensitive for low D-dimer levels and wild-range assays of D-dimers. Some D-dimer assays might therefore be more useful than others for diagnosing low levels of D-dimer. Although the measurement of D-dimer levels was useful for diagnosing subclinical DVT and predicting the risk of DVT, the cutoff values for the diagnosis or prediction of DVT varied. The cutoff values for the prediction of postoperative DVT were ≥1.7 µg/mL (D-dimer A-D) and ≥1.0 µg/mL (D-dimer E-H).

Entities:  

Keywords:  D-dimer; DVT; cutoff value; orthopedic surgery

Mesh:

Substances:

Year:  2017        PMID: 28480752      PMCID: PMC6714702          DOI: 10.1177/1076029617706755

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  29 in total

Review 1.  Prevention of venous thromboembolism.

Authors:  W H Geerts; J A Heit; G P Clagett; G F Pineo; C W Colwell; F A Anderson; H B Wheeler
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

2.  The Fibrin Assay Comparison Trial (FACT): evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. FACT study group.

Authors:  C E Dempfle; S Zips; H Ergül; D L Heene
Journal:  Thromb Haemost       Date:  2001-04       Impact factor: 5.249

3.  Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double-blind, placebo-controlled trial.

Authors:  J A Heit; C G Elliott; A A Trowbridge; B F Morrey; M Gent; J Hirsh
Journal:  Ann Intern Med       Date:  2000-06-06       Impact factor: 25.391

4.  Negative predictive value of D-dimer for diagnosis of venous thromboembolism.

Authors:  Hideki Nomura; Hideo Wada; Toshiro Mizuno; Naoyuki Katayama; Yasunori Abe; Maki Noda; Kaname Nakatani; Takeshi Matsumoto; Satoshi Ota; Norikazu Yamada; Akihiro Sudo; Atsumasa Uchida; Tsutomu Nobori
Journal:  Int J Hematol       Date:  2008-02-19       Impact factor: 2.490

5.  Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge.

Authors:  C W Colwell; D K Collis; R Paulson; J W McCutchen; G T Bigler; S Lutz; M E Hardwick
Journal:  J Bone Joint Surg Am       Date:  1999-07       Impact factor: 5.284

6.  Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography.

Authors:  F Piovella; C-J Wang; H Lu; K Lee; L H Lee; W C Lee; A G G Turpie; A S Gallus; A Planès; R Passera; A Rouillon
Journal:  J Thromb Haemost       Date:  2005-12       Impact factor: 5.824

7.  Elevated levels of soluble fibrin or D-dimer indicate high risk of thrombosis.

Authors:  H Wada; T Kobayashi; Y Abe; T Hatada; N Yamada; A Sudo; A Uchida; T Nobori
Journal:  J Thromb Haemost       Date:  2006-06       Impact factor: 5.824

Review 8.  Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  William H Geerts; Graham F Pineo; John A Heit; David Bergqvist; Michael R Lassen; Clifford W Colwell; Joel G Ray
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

9.  Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis.

Authors:  Philip S Wells; David R Anderson; Marc Rodger; Melissa Forgie; Clive Kearon; Jonathan Dreyer; George Kovacs; Michael Mitchell; Bernard Lewandowski; Michael J Kovacs
Journal:  N Engl J Med       Date:  2003-09-25       Impact factor: 91.245

10.  Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality.

Authors:  Alexander T Cohen; Giancarlo Agnelli; Frederick A Anderson; Juan I Arcelus; David Bergqvist; Josef G Brecht; Ian A Greer; John A Heit; Julia L Hutchinson; Ajay K Kakkar; Dominique Mottier; Emmanuel Oger; Meyer-Michel Samama; Michael Spannagl
Journal:  Thromb Haemost       Date:  2007-10       Impact factor: 5.249

View more
  1 in total

1.  Application value of D-dimer testing and Caprini risk assessment model (RAM) to predict venous thromboembolism (VTE) in Chinese non-oncological urological inpatients: a retrospective study from a tertiary hospital.

Authors:  Zi-Qiang Wu; Kai-Xuan Li; Quan Zhu; Hao-Zhen Li; Zheng-Yan Tang; Zhao Wang
Journal:  Transl Androl Urol       Date:  2020-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.